tirzepatide and retinopathy The popular #diabetes weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Type 2 diabetes: Tirzepatide linked

In recent years, a class of medications originally developed to treat Type 2 diabetes and obesity have emerged as a promising new frontier in the treatment of mental health disorders, including addiction and impulse control problems

Read more about the trial and what scientists have to say about future trials with insights from Daniel Drucker, Sally A, and Paul Seidler: To view or add a comment, sign in Cardiac arrhythmia management is complex and patient responses to medication can vary significantly

The relationship between semaglutide and leg cramps is not fully understood, but some patients have reported experiencing this side effect

Quarenghi M, Capelli S, Galligani G, et al

Monthly monitoring